Correspondence 0001193125-24-180395 from Iterum Therapeutics plc (ITRM) (CIK 0001659323) (ITRM)
Iterum Therapeutics plc (ITRM) (CIK 0001659323)
Date: July 17, 2024 · CIK: 0001659323 · Accession: 0001193125-24-180395
AI Filing Summary & Sentiment
File numbers found in text: 333-280045
Letter
Re: Iterum Therapeutics plc
July 17, 2024
VIA EDGAR SUBMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: Tim Buchmiller
Registration Statement on Form S-1
File No. 333-280045
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Iterum Therapeutics plc hereby requests acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-280045), as amended, so that it may become effective at 4:30 p.m., Eastern time, on July 19, 2024, or as soon as practicable thereafter.
Very truly yours,
ITERUM THERAPEUTICS PLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP July 17, 2024 VIA EDGAR SUBMISSION Securities and Exchange Commission Division of Corporation Finance 100 F Street, NE Washington, DC 20549 Attention: Tim Buchmiller Re: Iterum Therapeutics plc Registration Statement on Form S-1 File No. 333-280045 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Iterum Therapeutics plc hereby requests acceleration of the effective date of the Registration Statement on Form S-1 (File No. 333-280045), as amended, so that it may become effective at 4:30 p.m., Eastern time, on July 19, 2024, or as soon as practicable thereafter. Very truly yours, ITERUM THERAPEUTICS PLC By: /s/ Corey N. Fishman Name: Corey N. Fishman Title: Chief Executive Officer